Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Progress on mechanisms of age-related hearing loss. | Front Neurosci | 2023 | 37727326 | PubTator, text mining | PubMed |
| Clinical Significance of NAT2 Genetic Variations in Type II Diabetes Mellitus and Lipid Regulation. | Pharmgenomics Pers Med | 2023 | 37724295 | PubTator, text mining | PubMed |
| Bladder cancer course, four genetic high-risk variants, and histopathological findings. | EXCLI J | 2023 | 37720238 | PubTator, text mining | PubMed |
| N-acetyltransferase 2 genetic polymorphisms and anti-tuberculosis-drug-induced liver injury: a correlation study. | Front Pharmacol | 2023 | 37719844 | PubTator, text mining | PubMed |
| High-coverage genome of the Tyrolean Iceman reveals unusually high Anatolian farmer ancestry. | Cell Genom | 2023 | 37719142 | PubTator, text mining | PubMed |
| A case-control study in NAT2 gene polymorphism studies in patients diagnosed with acute myeloid leukemia. | Acta Biochim Pol | 2023 | 37715989 | PubTator, text mining | PubMed |
| Application of a physiologically based pharmacokinetic model to predict isoniazid disposition during pregnancy. | Clin Transl Sci | 2023 | 37712488 | PubTator, text mining | PubMed |
| Pharmacokinetic Assessment of Isoniazid and Acetylisoniazid in Carbon Tetrachloride-Induced Liver Injury Model in Wistar Rats. | J Pharm Bioallied Sci | 2023 | 37705856 | PubTator, text mining | PubMed |
| Pharmacogenetics of tuberculosis treatment toxicity and effectiveness in a large Brazilian cohort. | medRxiv | 2023 | 37693472 | PubTator, text mining | PubMed |
| Results from three phase 1 trials of NNC9204-1177, a glucagon/GLP-1 receptor co-agonist: Effects on weight loss and safety in adults with overweight or obesity. | Mol Metab | 2023 | 37690519 | PubTator, text mining | PubMed |
| O-GlcNAc transferase promotes glioblastoma by modulating genes responsible for cell survival, invasion, and inflammation. | J Biol Chem | 2023 | 37689115 | PubTator, text mining | PubMed |
| A Case-Only Genome-Wide Interaction Study of Smoking and Bladder Cancer Risk: Results from the COBLAnCE Cohort. | Cancers (Basel) | 2023 | 37686494 | PubTator, text mining | PubMed |
| Evaluation of Human Hepatocyte Drug Metabolism Carrying High-Risk or Protection-Associated Liver Disease Genetic Variants. | Int J Mol Sci | 2023 | 37686209 | PubTator, text mining | PubMed |
| The role of SOD2 and NOS2 genes in the molecular aspect of bladder cancer pathophysiology. | Sci Rep | 2023 | 37660159 | PubTator, text mining | PubMed |
| Reaction Pathways in Carbonates and Esters. | ChemSusChem | 2023 | 37655902 | PubTator, text mining | PubMed |
| Orofacial Clefts: Genetics of Cleft Lip and Palate. | Genes (Basel) | 2023 | 37628654 | PubTator, text mining | PubMed |
| Discovery of a novel genetic variant in the N-acetyltransferase2 (NAT2) gene that is associated with bladder cancer risk. | Acta Biochim Pol | 2023 | 37595067 | PubTator, text mining | PubMed |
| The effect of the rs1799931 G857A (G286E) polymorphism on N-acetyltransferase 2-mediated carcinogen metabolism and genotoxicity differs with heterocyclic amine exposure. | Arch Toxicol | 2023 | 37592049 | PubTator, text mining | PubMed |
| Epidemiology and Management of Drug-induced Liver Injury: Importance of the Updated RUCAM. | J Clin Transl Hepatol | 2023 | 37577239 | PubTator, text mining | PubMed |
| The role of Mycobacterium tuberculosis acetyltransferase and protein acetylation modifications in tuberculosis. | Front Cell Infect Microbiol | 2023 | 37560320 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=12